Bio-Works Technologies AB (publ)
STO: BIOWKS.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Lone Carlbom
- Employees
- 30
- Headquarters
- Uppsala, Sweden
- IPO year
- 2017
- Market cap
- SEK 259.9M
- Website
- https://www.bio-works.com
Loading BIOWKS…
Loading profile data…Frequently asked questions about BIOWKS
What does Bio-Works Technologies AB (publ) (BIOWKS.ST) do?
Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; BabyBio columns; immobilized metal-ion affinity chromatography resins; ion exchange resins...
Where does BIOWKS.ST trade?
Bio-Works Technologies AB (publ) (BIOWKS.ST) trades on the Stockholm Stock Exchange.
What sector is BIOWKS.ST in?
Bio-Works Technologies AB (publ) (BIOWKS.ST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Bio-Works Technologies AB (publ)?
Lone Carlbom is the chief executive officer of Bio-Works Technologies AB (publ) (BIOWKS.ST).
Where is Bio-Works Technologies AB (publ) headquartered?
Bio-Works Technologies AB (publ) is headquartered in Sweden.
Does BIOWKS.ST pay a dividend?
Bio-Works Technologies AB (publ) (BIOWKS.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BIOWKS.ST go public?
Bio-Works Technologies AB (publ) (BIOWKS.ST) completed its initial public offering in 2017.